Accolade Welcomes Kindbody to Trusted Partner Ecosystem [Yahoo! Finance]
Accolade, Inc. - common stock (ACCD)
Company Research
Source: Yahoo! Finance
SEATTLE Jan. 23, 2024 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD) today announced that Kindbody, a technology-driven fertility clinic network and family-building benefits provider for employers, will join the company's Trusted Partner Ecosystem to offer Accolade customers comprehensive, clinically guided support and care throughout a member's fertility and family-building journey, all backed by a new cost savings performance guarantee. Approximately one in six couples are affected by infertility in the United States . Yet fertility and family-building services are fragmented and siloed, and employees often struggle to find support in the workplace when facing infertility and subsequent treatment, as many employer-based insurance plans do not cover the high cost of fertility treatment. Kindbody addresses these issues by providing affordable fertility care and delivering a seamless, integrated experience with best-in-class outcomes. Kindbody's physician-led clinical model support
Show less
Read more
Impact Snapshot
Event Time:
ACCD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACCD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACCD alerts
High impacting Accolade, Inc. - common stock news events
Weekly update
A roundup of the hottest topics
ACCD
News
- Accolade, Inc. (NASDAQ: ACCD) had its price target lowered by analysts at Wells Fargo & Company from $12.00 to $10.00. They now have an "equal weight" rating on the stock.MarketBeat
- Accolade, Inc. (NASDAQ:ACCD) Q4 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Accolade, Inc. (NASDAQ: ACCD) had its price target lowered by analysts at Morgan Stanley from $13.00 to $12.00. They now have an "equal weight" rating on the stock.MarketBeat
- Accolade, Inc. (NASDAQ: ACCD) had its price target lowered by analysts at Truist Financial Co. from $16.00 to $14.00. They now have a "buy" rating on the stock.MarketBeat
- Accolade, Inc. (NASDAQ: ACCD) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $18.00 to $16.00. They now have a "buy" rating on the stock.MarketBeat
ACCD
Earnings
- 4/25/24 - Beat
ACCD
Sec Filings
- 5/2/24 - Form 144
- 5/2/24 - Form 144
- 4/26/24 - Form S-8
- ACCD's page on the SEC website